Blackstone Group Inc
NYSE: BX · FINANCIAL SERVICES · ASSET MANAGEMENT
Updated 2026-04-29
Blackstone Group Inc (BX) Financial Forecast & Price Target 2030
Research-backed projections from analyst consensus, management guidance, and sector analysis.
Price target summary
Management guidance
No specific management revenue targets found in available data. Recent announcements highlight $6.3B life sciences fund close and continued fundraising strength, suggesting momentum in AUM growth and fee-generating assets. Company emphasizes private credit expansion and alternative asset class positioning.
Revenue & price projection
Financial forecast — research-backed
| Metric | 2023 | 2024 | 2025 | 2026 (E) | 2027 (E) | 2028 (E) | 2029 (E) | 2030 (E) |
|---|---|---|---|---|---|---|---|---|
| Revenue | $7.4B | $11.4B | $13.8B | $16.3B | $19.8B | $23.9B | $28.6B | $34.3B |
| Revenue growth | — | 52.9% | 21.6% | 14.6% | 21.8% | 20.3% | 20.0% | 20.0% |
| EPS | $3.95 | $4.64 | $5.57 | $6.58 | $8.20 | $9.85 | $11.82 | $14.18 |
| P/S ratio | — | — | — | 12.0x | 12.0x | 12.0x | 12.0x | 12.0x |
| Implied price | — | — | — | $158.27 | $192.19 | $226.10 | $282.63 | $327.85 |
Catalysts & risks
Methodology
Blackstone Group Inc's forward estimates are derived from AI-powered research synthesis combining analyst consensus from 16 Wall Street analysts, management guidance from the latest earnings call, and sector growth forecasts from industry research. Revenue and EPS projections use analyst consensus where available and conservative extrapolation with growth deceleration for outer years. Price targets are calculated using a tiered Price-to-Sales (P/S) methodology, where the P/S multiple is determined by the projected revenue growth rate.
WallStSmart proprietary research model · Not financial advice · Past performance is not indicative of future results · Last researched: April 6, 2026.